Page 285 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 285

CHAPTER 15  Diuretic Agents     271


                    usually be avoided because it causes NaHCO  excretion and can   may actually contribute to the syndrome and should be ruled
                                                       3
                    exacerbate acidosis. Potassium-sparing diuretics may cause hyper-  out before additional therapy is pursued. While spironolactone
                    kalemia. Thiazide diuretics are thought to be ineffective when   has been used for idiopathic edema, it should probably be man-
                    GFR falls below 30 mL/min, although the exact GFR at which   aged with moderate salt restriction alone if possible. Compres-
                    they no longer prove to be beneficial is still a matter of debate. In   sion stockings have also been used but appear to be of variable
                    addition, it has been found that thiazides can be used to signifi-  benefit.
                    cantly reduce the dose of loop diuretics needed to promote diure-
                    sis in a patient with a GFR of 5–15 mL/min. Thus, high-dose
                    loop diuretics (up to 500 mg/d of furosemide) or a combination   NONEDEMATOUS STATES
                    of metolazone (5–10 mg/d) with furosemide (40–80 mg/d) may
                    be useful in treating volume  overload  in dialysis or predialysis   HYPERTENSION
                    patients. Finally, although excessive use of diuretics can impair
                    renal function in all patients, the consequences are obviously more   The diuretic and mild vasodilator actions of the thiazides are use-
                    serious in patients with underlying renal disease.   ful in treating virtually all patients with essential hypertension and
                                                                         may be sufficient in many (see also Chapter 11). Although hydro-
                                                                         chlorothiazide is the most widely used diuretic for hypertension,
                    HEPATIC CIRRHOSIS                                    chlorthalidone may be more effective because of its much longer
                                                                         half-life. Loop diuretics are usually reserved for patients with mild
                    Liver disease is often associated with edema and ascites in con-  renal insufficiency (GFR < 30–40 mL/min) or heart failure. Mod-
                    junction with elevated portal hydrostatic pressures and reduced   erate restriction of dietary Na  intake (60–100 mEq/d) has been
                                                                                                +
                                                                +
                    plasma oncotic pressures. Mechanisms for retention of Na  by the   shown to potentiate the effects of diuretics in essential hyperten-
                    kidney in this setting include diminished renal perfusion (from   sion and to lessen renal K  wasting. A K -sparing diuretic can be
                                                                                             +
                                                                                                        +
                    systemic vascular alterations), diminished plasma volume (due to   added to reduce K  wasting.
                                                                                       +
                    ascites formation),  and  diminished oncotic  pressure  (hypoalbu-  There has been debate about whether thiazides should be used
                                                          +
                    minemia). In addition, there may be primary Na  retention due   as the initial therapy in the treatment of hypertension. Their mod-
                    to elevated plasma aldosterone levels.               est efficacy sometimes limits their use as monotherapy. However,
                       When ascites and edema become severe, diuretic therapy can   a very large study of over 30,000 participants has shown that
                    be very useful. However, cirrhotic patients are often resistant to   inexpensive diuretics like thiazides result in outcomes that are
                    loop diuretics because of decreased secretion of the drug into the   similar or superior to those found with ACE inhibitor or calcium
                    tubular fluid and because of high aldosterone levels. In contrast,   channel-blocker  therapy.  This  significant  result  reinforces the
                    cirrhotic edema is unusually responsive to spironolactone and   importance of thiazide therapy in hypertension.
                    eplerenone. The combination of loop diuretics and an aldosterone   Although diuretics are often successful as monotherapy, they
                    receptor antagonist may be useful in some patients. However, con-  also play an important role in patients who require multiple drugs
                    siderable caution is necessary in the use of aldosterone antagonists   to control blood pressure. Diuretics enhance the efficacy of many
                    in cirrhotic patients with even mild renal insufficiency because of   agents, particularly ACE inhibitors. Patients being treated with
                    the potential for causing serious hyperkalemia.      powerful  vasodilators  such  as  hydralazine  or  minoxidil  usually
                       It is important to note that, even more than in heart failure,   require simultaneous diuretics because the vasodilators cause sig-
                    overly aggressive use of diuretics in this setting can be disastrous.   nificant salt and water retention. There is also growing evidence
                    Vigorous diuretic therapy can cause marked depletion of intravas-  showing that spironolactone may be the most effective single agent
                    cular volume, hypokalemia, and metabolic alkalosis. Hepatorenal   in the therapy of drug-resistant hypertension, and this effect may
                    syndrome and hepatic encephalopathy are the unfortunate conse-  extend to dialysis patients.
                    quences of excessive diuretic use in the cirrhotic patient. Vaptans
                    are relatively contraindicated in patients with liver disease because   NEPHROLITHIASIS
                    a study of tolvaptan in treating patients with autosomal dominant
                    polycystic kidney disease resulted in increased transaminases in   Approximately two thirds of kidney stones contain Ca  phosphate
                                                                                                                 2+
                    some patients treated with high-dose tolvaptan. Low-dose tolvap-  or Ca  oxalate. Although there are numerous medical conditions
                                                                             2+
                    tan, however, may prove to be useful in treating some patients   (hyperparathyroidism, hypervitaminosis D, sarcoidosis, malignan-
                    with cirrhosis (those who do not have ongoing liver damage) who   cies, etc) that cause hypercalciuria, many patients with such stones
                    suffer from hyponatremia or fluid overload.                                        2+
                                                                         exhibit a defect in proximal tubular Ca  reabsorption. This can
                                                                                                                 2+
                                                                         be treated with thiazide diuretics, which enhance Ca  reabsorp-
                    IDIOPATHIC EDEMA                                     tion in the DCT and thus reduce the urinary Ca  concentration.
                                                                                                              2+
                                                                         Fluid intake should be increased, but salt intake must be reduced,
                    Idiopathic edema (fluctuating salt retention and edema) is a   since excess dietary NaCl will overwhelm the hypocalciuric effect
                                                                                           2+
                    syndrome found most often in 20- to 30-year-old women.   of thiazides. Dietary Ca  should not be restricted, as this can lead
                                                                                            2+
                    Despite intensive study, the pathophysiology remains obscure.   to negative total body Ca  balance. Calcium stones may also be
                                                                                                              2+
                    Some studies suggest that surreptitious, intermittent diuretic use   caused by increased intestinal absorption of Ca , or they may
   280   281   282   283   284   285   286   287   288   289   290